About 3 results found for searched term "CDDO-Im" (0.127 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M11194 | CDDO-3-P-Im | Apoptosis |
| CPD1599;CPDB1599 | ||
| Cddo-3p-im is a CDDO imidazolid analogue with chemoprophylaxis. Cddo-3p-im can reduce the size and severity of lung tumors in mouse lung cancer models. | ||
| M11195 | CDDO-2-P-Im | Apoptosis |
| CPD1589;CPDB1589 | ||
| Cddo-2p-im is a CDDO imidazolid analogue with chemoprophylaxis. Cddo-2p-im reduced the size and severity of lung tumors in mouse lung cancer models. Cddo-2p-im is an orally active necroptosis inhibitor that can be used in ischemia/reperfusion (I/R) studies. | ||
| M11261 | CDDO-Im | Keap1-Nrf2 |
| RTA-403; TP-235; CDDO-Imidazolide | ||
| CDDO Im (RTA-403) is the activator of Nrf2 and PPAR with Ki of 232 nM and 344 nM for PPARα and PPARγ, respectively. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
